[Identification of a de novo MAP2K1 gene variant in an affected patient with Cardio-facio-cutaneous syndrome]

Wang Q, Chen P, Peng Q, Liu J, Huang Y, Tang Z, Liu Y, Yuan H.Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 May 10;37(5):567-569. doi: 10.3760/cma.j.issn.1003-9406.2020.05.018.PMID: 32335888 Chinese.

 

Abstract

Objective: To explore the genotype-phenotype correlation of Cardio-facio-cutaneous syndrome (CFCS) caused by MAP2K1 gene variants.

Methods: Genomic DNA was extracted from peripheral blood sample from a child patient and his parents. Whole exome sequencing (WES) was carried out for the patient. Suspected variant was verified by Sanger sequencing.

Results: The patient was a 1-year-8-month old Chinese male who manifested short stature, psychomotor retardation, relative macrocephaly, distinctive facial features, and congenital heart disease. WES test revealed a heterozygous missense c.389A>G (p.Tyr130Cys) variant in the MAP2K1 gene. Sanger sequencing has confirmed the variant as de novo. According to ACMG/AMP guidelines, the variant was classified as pathogenic.

Conclusion: Compared with previously reported CFCS cases due to MAP2K1 variants. The patient showed obvious behavioral problems, good appetite and tricuspid regurgitation, which may to be novel features for CFCS.

 

source:https://pubmed.ncbi.nlm.nih.gov/32335888/

0 Comments